4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-24-047641
Options or other derivatives
- CEO bought 80,365 shares at $2.86 ($230,005)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Pershing Edward CEO | 2024-11-22 | Purchase · Series D-1 Convertible Preferred Stock | +80,365 | $2.86 | $230,005 | 1,691,704 | D |
Loading xslF345X05/ownership.xml…